FDA OKs novel IV treatment Olinvyk for acute pain

The FDA has approved Olinvyk — the first new IV chemical opioid agonist in decades — for adults with acute pain, the drug’s manufacturer announced.
Olinvyk (oliceridine, Trevena) is intended for patients with pain “severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate,” the manufacturer said.
Trevena said the safety and efficacy of oliceridine were established in trials totaling 1,535 patients who were older, obese, diabetic and/or had sleep apnea and underwent orthopedic surgery-bunionectomy or plastic

Source link

Related posts

Vosevi safely treats HCV in patients with prior treatment failure


Colorectal Cancer Screening for Lynch Syndrome: Age-Restricted or Universal?


Multidisciplinary care improves functional GI symptoms


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World